开发LIS功能实现新型冠状病毒核酸及抗体检测结果自动审核和综合报告

Developing LIS function to realize automatic review and comprehensive report of SARS-CoV-2 nucleic acid and antibody detection results

目的通过开发实验室信息管理系统(LIS)功能,实现新型冠状病毒(SARS-CoV-2)核酸及抗体检测结果自动审核和综合报告。方法根据SARS-CoV-2检测流程的风险控制需求、检测结果报告要求,使用金域医学自行开发的自动审核系统设置20条规则,包括3条审核类规则和17条解释类规则。LIS对SARS-CoV-2核酸和抗体检测结果自动审核并综合至1张报告单,实现自动报告。结果LIS成功进行结果审核和综合,2020年3月15日至22日,结果解释类规则使用率为99.68%,结果审核类规则使用率为0.32%。自动审核使标本周转时间缩短了2.7 h;截至2021年1月13日,尚未发现任何LIS执行缺陷。结论通过自动审核和综合报告可以控制内部风险,提供结果解释,提升报告处理效率和临床服务质量,为检验与临床的良性互动提供保障。

Objective Through the development of the laboratory information management system(LIS)function,to realize the automatic review and comprehensive report of SARS-CoV-2 nucleic acid and antibody detection results.Methods According to the risk control requirements of the SARS-CoV-2 detection process and the detection result report requirements,20 rules were set up using the automatic review system developed by Kingmed Diagnostics,included 3 review rules and 17 interpretation rules.LIS automatically reviewed the results of SARS-CoV-2 nucleic acid and antibody detection and integrated them into a single report to realized automatic reporting.Results LIS successfully conducted result review and comprehensive.March 15 to 22,2020,the use rate of result interpretation rules was 99.68%,and the use rate of result review rules was 0.32%.The automatic review reduced the turnaround time of samples by 2.7 h,and as of January 13,2021,no LIS execution defects was found.Conclusion Automatic review and comprehensive report could control internal risks,provide result interpretation,improve report processing efficiency and clinical service quality,and provide guarantee for the benign interaction between laboratory and clinic.